While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback